Products & Reviews

Enzyme Immunoassay for the quantitative determination of Denosumab (PROLIA) in serum, plasma and cell culture supernatant

Enzyme Immunoassay for the quantitative determination of Vedolizumab (ENTYVIO) in serum, plasma and cell culture supernatant

The Eculizumab (Soliris) ELISA kit is intended for the quantitative determination of Eculizumab (Soliris) in serum, plasma and cell culture samples. CE IVD marked. Key features: -uses highly specific monoclonal anti-idiotypic antibodies -calibrator used is commerically available eculizumab injection itself -Recovery: 80-120% -Precision CV

Enzyme Immunoassay for the quantitative determination of Ixekizumab in serum and plasma.

Enzyme Immunoassay for the quantitative determination of Secukinumab in serum and plasma.

Enzyme Immunoassay for the quantitative determination of Sunitinib in serum, plasma and cell culture supernatant

ELISA for the detection of Catumaxomab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year

Enzyme Immunoassay for the Quantitative Determination of Emicizumab in human Serum and Plasma

ELISA for the detection of Glofitamab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year

ELISA for the detection of Epcoritamab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year